Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACYW135 Meningococcal Conjugate Vaccine Phase III Trial in Chinese Children, Adolescents and Adults
CTR20220469Phase 3Completed
- Sponsor
- Yuxi Watson Biotechnology
- Start
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal groups a, c, y and w135 polysaccharide conjugate vaccine in meningococcal meningitis, sponsored by Yuxi Watson Biotechnology. Started Mar 2022; status: completed.
02
Drugs
meningococcal groups a, c, y and w135 polysaccharide conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20220469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220469.